Implementing a perinatal substance abuse screening tool

Advances in Neonatal Care

Volumn 11, Issue 4, 2011, Pages 255-267

  Wallman, Carol M ^a,b   Smith, Pat Bohling ^b   Moore, Karen ^b  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b Poudre Valley Hospital   (United States)

Author keywords

Alcohol; Illicit drugs; Newborns; Perinatal drug testing; Substance abuse; Universal screening

Indexed keywords

ADDICTION; ARTICLE; CHEMISTRY; FEMALE; HOSPITAL; HUMAN; INTERDISCIPLINARY COMMUNICATION; MECONIUM; MENTAL HEALTH SERVICE; METHODOLOGY; NEWBORN; NURSING EDUCATION; PERINATAL CARE; PREGNANCY; PSYCHOLOGIC TEST; SUBSTANCE ABUSE; UNITED STATES;

COLORADO; COMMUNITY MENTAL HEALTH SERVICES; EDUCATION, NURSING; FEMALE; HOSPITALS; HUMANS; INFANT, NEWBORN; INTERDISCIPLINARY COMMUNICATION; INTERVIEW, PSYCHOLOGICAL; MECONIUM; PERINATAL CARE; PREGNANCY; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 80053637385     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANC.0b013e318225a20b     Document Type: Article

References (20)

1. McGlade A, Ware R, Crawford M. Child protection outcomes for infants of substance-using mothers: a matched-cohort study. Pediatr. 2009;124:285-293.
2. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. 1996 National Household Survey on Drug Abuse. http://www.oas.samhsa.gov/p0000016.htm. Published 1996. Accessed March 11,2010.
3. Dalen K, Bruarøy S, Wentzel-Larsen T, Laegreid LM. Cognitive functioning in children prenatally exposed to alcohol and psychotropic drugs. Neuropediatr. 2009;40(4):162-167.
4. Hans-Ludwig S, Willms, J, Steinhausen H-C. Fetal alcohol spectrum disorders in young adulthood. J Pediatr. 2007;150:175-179.
5. March of Dimes. Illicit drug use during pregnancy. http://www. marchofdimes.com/professionals/14332-1169.asp#head5. Published January 2008. Accessed May 7, 2010.
6. Steinhausen HC, Blattmann B, Pfund F. Developmental outcome in children with intrauterine exposure to substances. Eur Addict Res. 2007;13:94-100. doi: 10.1159/000097939. (Pubitemid 46425821)
7. Queenan J, Spong C, Lockwood C. Management of High-risk Pregnancy: An Evidence-Based Approach. 5th ed. Malden, MA: Blackwell Publishing Ltd; 2007.
8. US Centers for Disease Control. Fetal alcohol syndrome: guidelines for referral and diagnosis. http://www.cdc.gov/ncbddd/fasd/documents/FAS-guidelines- accessible.pdf. Published June 30, 2005. Accessed April 14, 2010.
9. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. 2006 National Survey on Drug Use and Health. http://www.oas.samhsa.gov/nsduh/2k6nsduh/2k6Results.cfm#TOC. Published2006. Accessed May 5, 2010.
10. US Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Fetal alcohol spectrum disorders by the numbers.http://fasdcenter.samhsa.gov/documents/WYNK-Numbers.pdf. Published January 9, 2006. Accessed April 13, 2010.
11. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Alcohol use among pregnant women and recent mothers 2002-2007. http://www.oas.samhsa.gov/2k8/pregnantAlc/pregnantAlc.pdf. Published August 19, 2008. Accessed April 14, 2010.
12. Office of Disease Prevention and Health Promotion. Healthy People 2010. Objective for Improving Health (Part B). Washington, DC: US Department of Health and Human Services; 2001.
13. Office of Disease Prevention and Health Promotion. Healthy people 2020. Objective for improving health. http://www.healthypeople.gov/HP2020/Objectives/ TopicArea.aspx?id-46&TopicArea-Substance-Abuse. Published 2009. Accessed April 12, 2010.
14. American Congress of Obstetricians and Gynecologists. All patients should be asked about alcohol and drug use. http://www.acog.org/from-home/ publications/press-releases/nr12-12-08.cfm. Published December 12, 2008. Accessed June 1,2010.
15. Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance Abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J. Perinatol. 2008:28(9):597-603.
16. Chasnoff IJ, Wells AM, McGourty RF, Bailey LK. Validation of the 4P' s Plus Screen for substance use in pregnancy. J Perinatol. 2007;27:744-748.
17. United States Drug Testing Laboratories. MecSTAT-MecSTAT-EtOH Collection and Shipping Instructions. Des Plaines, IL: United States Drug Testing Laboratories.
18. Richie B. Fetal Alcohol Spectrum Disorders (FASD) Exposure Rates, Primary and Cascade Results of in utero Alcohol Exposure, and Incidence Markers. Brights Grove, Ontario, Canada: FASlink Fetal Alcohol Disorders Society; 2007.http://www.faslink.org/probabilityofprenatalalcoholexposure.pdf. Published 2007. Accessed May 6, 2010.
19. Keough V, Jennrich J. Including a screening and brief alcohol intervention program in the care of the obstetric patient. JOGNN. 2009;38(6):715-721.
20. Sampson PD, Streissguth AP, Bookstein FL, et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1999;60(2):51-52.